63 related articles for article (PubMed ID: 27231694)
1. Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief Report.
Sarcon A; Botta GP; Patel N; Saven A
J Investig Med High Impact Case Rep; 2016; 4(2):2324709616648457. PubMed ID: 27231694
[TBL] [Abstract][Full Text] [Related]
2. The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia.
Ababneh O; Abushukair H; Qarqash A; Syaj S; Al Hadidi S
Clin Hematol Int; 2022 Jun; 4(1-2):21-29. PubMed ID: 35950210
[TBL] [Abstract][Full Text] [Related]
3. Imbruvica (Ibrutinib): First Drug Approved for the Treatment of Patients with Waldenström's Macroglobulinemia.
Raedler LA
Am Health Drug Benefits; 2016 Mar; 9(Spec Feature):89-92. PubMed ID: 27668052
[No Abstract] [Full Text] [Related]
4. Ibrutinib-Associated Skin Toxicity: A Case of Maculopapular Rash in a 79-Year Old Caucasian Male Patient with Relapsed Waldenstrom's Macroglobulinemia and Review of the Literature.
Jensen AB; Stausbøl-Grøn B; Riber-Hansen R; d'Amore F
Dermatol Reports; 2017 Mar; 9(1):6976. PubMed ID: 28469834
[TBL] [Abstract][Full Text] [Related]
5. Current and novel BTK inhibitors in Waldenström's macroglobulinemia.
Ntanasis-Stathopoulos I; Gavriatopoulou M; Fotiou D; Dimopoulos MA
Ther Adv Hematol; 2021; 12():2040620721989586. PubMed ID: 33613931
[TBL] [Abstract][Full Text] [Related]
6. A case of new-onset cardiomyopathy and ventricular tachycardia in a patient receiving ibrutinib for relapsed mantle cell lymphoma.
Wallace N; Wong E; Cooper D; Chao H
Clin Case Rep; 2016 Dec; 4(12):1120-1121. PubMed ID: 27980745
[TBL] [Abstract][Full Text] [Related]
7. The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia.
Khan AM
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629099
[TBL] [Abstract][Full Text] [Related]
8. Serositis causing pericardial and pleural effusions after eight years of maintenance ibrutinib for Waldenstrom's macroglobulinemia.
Johnson G; Baviriseaty N; Massanet N; Kooper J
J Oncol Pharm Pract; 2023 Apr; ():10781552231171925. PubMed ID: 37097903
[TBL] [Abstract][Full Text] [Related]
9. HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom's Macroglobulinemia.
Wallace MR
Case Rep Infect Dis; 2020; 2020():6516037. PubMed ID: 32274227
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID-19 infection: Case report and literature review.
Lin AY; Cuttica MJ; Ison MG; Gordon LI
EJHaem; 2020 Nov; 1(2):596-600. PubMed ID: 33043320
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia and lymphoma.
Varma G; Johnson TP; Advani RH
Clin Adv Hematol Oncol; 2016 Jul; 14(7):543-54. PubMed ID: 27379948
[TBL] [Abstract][Full Text] [Related]
12. Severe Hepatotoxicity due to Ibrutinib with a Review of Published Cases.
Tafesh ZH; Coleman M; Fulmer C; Nagler J
Case Rep Gastroenterol; 2019; 13(2):357-363. PubMed ID: 31607836
[TBL] [Abstract][Full Text] [Related]
13. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Maddocks K; Jones JA
Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
[TBL] [Abstract][Full Text] [Related]
14. Imbruvica (Ibrutinib), First-in-Class Bruton's Tyrosine Kinase Inhibitor, Receives Expanded Indications for Patients with Relapsed Chronic Lymphocytic Leukemia.
Raedler LA
Am Health Drug Benefits; 2015 Mar; 8(Spec Feature):66-9. PubMed ID: 26629268
[No Abstract] [Full Text] [Related]
15. [Waldenström's macroglobulinemia].
Watanabe R
Rinsho Ketsueki; 2015 Oct; 56(10):2074-85. PubMed ID: 26458447
[TBL] [Abstract][Full Text] [Related]
16. [New developments in Waldenström's macroglobulinemia].
Grunenberg A; Buske C
Dtsch Med Wochenschr; 2016 Feb; 141(3):170-2. PubMed ID: 26841176
[TBL] [Abstract][Full Text] [Related]
17. A Novel Finding of Lichenoid Drug Reaction From Ibrutinib Therapy.
Reji M; Shah KK
Cureus; 2022 Feb; 14(2):e22433. PubMed ID: 35371696
[TBL] [Abstract][Full Text] [Related]
18. BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma.
Wiestner A
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):125-34. PubMed ID: 25696845
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
Parmar S; Patel K; Pinilla-Ibarz J
P T; 2014 Jul; 39(7):483-519. PubMed ID: 25083126
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical approval update.
Goldenberg MM
P T; 2014 Apr; 39(4):262-96. PubMed ID: 24757362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
